{"id":27791,"date":"2024-08-07T09:27:39","date_gmt":"2024-08-07T07:27:39","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=27791"},"modified":"2024-08-07T10:29:48","modified_gmt":"2024-08-07T08:29:48","slug":"cinven-to-become-lead-investor-in-vitamin-well","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/en\/assignment\/cinven-to-become-lead-investor-in-vitamin-well\/","title":{"rendered":"Cinven to become lead investor in Vitamin Well"},"content":{"rendered":"<p class=\"preamble\">Cinven, an international private equity firm focused on building world-class global and European companies, has reached an agreement to become the lead investor in Vitamin Well, a Swedish provider of protein bars and sport and health beverages.<\/p>\n<p>Going forward, Bridgepoint, the current majority investor, will retain a significant minority stake in Vitamin Well. The transaction is subject to regulatory approvals and other customary closing conditions.<\/p>\n<p>Vitamin Well, with its headquarters in Stockholm, was established 2008 and is a fast-growing functional food and beverage business, offering premium products for health-conscious and active consumers. Vitamin Well has approximately 500 employees and a broad product portfolio across several brands, including Vitamin Well, NOCCO and Barebells, which are sold internationally across more than 40 markets.<\/p>\n<p>Cinven was advised on the transaction by Mannheimer Swartling, who partnered with the global law firm Freshfields Bruckhaus Deringer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cinven, an international private equity firm focused on building world-class global and European companies, has reached an agreement to become the lead investor in Vitamin\u2026<\/p>\n","protected":false},"author":16,"featured_media":27788,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4313],"tags":[],"class_list":["post-27791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-assignment","business-group-healthcare-and-life-sciences","business-group-mergers-and-acquisitions","business-group-private-equity"],"acf":[],"lang":"en","translations":{"en":27791,"sv":27786},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/27791"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=27791"}],"version-history":[{"count":2,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/27791\/revisions"}],"predecessor-version":[{"id":27793,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/27791\/revisions\/27793"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media\/27788"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=27791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=27791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=27791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}